| Dr Phillip E Noel, MD | |
|
2615 North Dr, Abbeville, LA 70510-4042 | |
| (337) 898-3700 | |
| (337) 898-3702 |
| Full Name | Dr Phillip E Noel |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 33 Years |
| Location | 2615 North Dr, Abbeville, Louisiana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477550499 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 09318R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbeville General Hospital | Abbeville, LA | Hospital |
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Entity Name | Phillip E. Noel, Md, Apmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538378583 PECOS PAC ID: 6406899541 Enrollment ID: O20050609000057 |
News Archive
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.
The American Academy of Neurology is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Southern Ent Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083713101 PECOS PAC ID: 0042313504 Enrollment ID: O20070321000477 |
News Archive
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.
The American Academy of Neurology is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Lsuhn Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.
The American Academy of Neurology is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Entity Name | Noel & Hanby Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922361260 PECOS PAC ID: 4880848290 Enrollment ID: O20130213000173 |
News Archive
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.
The American Academy of Neurology is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Phillip E Noel, MD 604 N Acadia Rd Ste 101, Thibodaux, LA 70301-4897 Ph: (985) 446-5079 | Dr Phillip E Noel, MD 2615 North Dr, Abbeville, LA 70510-4042 Ph: (337) 898-3700 |
News Archive
MGB Biopharma and Almac's Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3.
Concateno (>Europe's leading drug and alcohol test provider, has been awarded the prestigious Queen's Award for Enterprise (http://www.queensawards.org.uk/business/business.html ) in recognition of its outstanding innovation and commercial performance.
The American Academy of Neurology is awarding its 2011 Potamkin Prize to three researchers for their work in dementia. Dennis Dickson, MD, with the Mayo Clinic in Jacksonville, Florida, Eva Maria Mandelkow, MD, PhD, and Eckhard Mandelkow, PhD, both of the Max-Planck-Unit for Structural Molecular Biology in Hamburg, Germany, will receive the Award during the AAN's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 3 days ago